Prisons Evaluation of a One-stop-shop InterVentiOn

Last updated on July 2021

Conditions: Hepatitis C
Type: Interventional
Phase: Not Applicable
Design: Allocation: Non-RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: This study will be conducted as an interventional cohort study with a primary objective of assessing the effect of an intervention integrating point-of-care HCV RNA testing, non-invasive liver fibrosis assessment, same-visit DAA therapy, and linkage to hepatitis care, on the proportion of participants initiating DAA therapy among people who are recently incarcerated within reception correctional centre(s) in Australia. During the initial control period, all people who are newly incarcerated (in the previous six weeks) will be offered participation and will receive the standard of care with the current health service model. After a control period of approximately 12 weeks (dependent on recruitment rate) to enrol n=240 individuals, all people who are newly incarcerated (in the previous six weeks) will be offered participation in the intervention period which will continue for approximately 24 weeks (dependent on recruitment rate) to enrol n=480 individuals.Masking: None (Open Label)Primary Purpose: Health Services Research

Not Provided

NCT #: NCT04809246
Collaborators: Justice Health & Forensic Mental Health Network NSW Australia
Investigators: Principal Investigator: Andrew Lloyd, Prof Kirby Institute, University NSW